Mexico receives 2,8 million doses of Cuban anticovid vaccines

Photo of author


In an official dispatch, the health ministry reminded that on the 29th of December, 2021, the Federal Commission for the Protection Against Sanitary Risks ( FCPASR) ruled as appropriate the authorization for emergency use of the Cuban immunogen.

This ruling was approved under the distinctive denomination of recombination protein of the SARS-CoV-2 virus receptor binding domain, developed by the Center for Genetic Engineering and Biotechnology of the Ministry of Public Health of Cuba.

The National Vaccination Campaign against Influenza and COVID-19 for the winter season, 2023-2024 is ongoing in Mexico from the 16th of October 2023 until the 31st of March 2024. During this period 54 million 600 thousand doses will be applied.


Leave a comment